A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Clinical trial NCT01026727 · TERMINATED
Trial details
- NCT number
- NCT01026727
- Sponsor
- Myrexis Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2010-06-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.